| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.603 | 0.018 | 0.603 | Cholesterol antagonist | 0.422 0.045 DBMET00507 | ||
| 0.575 | 0.022 | 0.586 | Aldehyde oxidase inhibitor | 0.586 0.021 DBMET00507 | DBMET00507 | |
| 0.582 | 0.031 | 0.582 | Cyclophilin D inhibitor | 0.425 0.078 DBMET00507 | ||
| 0.526 | 0.032 | 0.526 | Antiobesity | |||
| 0.495 | 0.005 | 0.495 | 5 Hydroxytryptamine uptake stimulant | 0.416 0.012 DBMET00507 | ||
| 0.514 | 0.025 | 0.514 | 5 Hydroxytryptamine release stimulant | 0.28 0.076 DBMET00507 | ||
| 0.491 | 0.005 | 0.605 | Alpha-N-acetylglucosaminidase inhibitor | 0.605 0.004 DBMET00507 | DBMET00507 | |
| 0.475 | 0.003 | 0.475 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.207 0.015 DBMET00507 | ||
| 0.472 | 0.008 | 0.472 | Calcium channel activator | 0.282 0.111 DBMET00507 | ||
| 0.494 | 0.034 | 0.538 | 5 Hydroxytryptamine release inhibitor | 0.538 0.022 DBMET00507 | DBMET00507 | |
| 0.477 | 0.033 | 0.608 | GABA C receptor rho-3 antagonist | 0.608 0.007 DBMET00507 | DBMET00507 | |
| 0.502 | 0.059 | 0.502 | Caspase 9 stimulant | 0.39 0.117 DBMET00507 | ||
| 0.433 | 0.023 | 0.433 | Hypoglycemic | 0.284 0.059 DBMET00507 | ||
| 0.41 | 0.009 | 0.41 | Amylase inhibitor | 0.194 0.046 DBMET00507 | ||
| 0.395 | 0.004 | 0.395 | Succinate dehydrogenase inhibitor | 0.308 0.009 DBMET00507 | ||
| 0.386 | 0.015 | 0.386 | Dual specificity phosphatase 3 inhibitor | |||
| 0.389 | 0.019 | 0.389 | RNA-directed DNA polymerase inhibitor | 0.176 0.14 DBMET00507 | ||
| 0.395 | 0.029 | 0.395 | Interleukin 2 agonist | 0.296 0.077 DBMET00507 | ||
| 0.418 | 0.069 | 0.418 | Calcium channel L-type activator | 0.397 0.083 DBMET00507 | ||
| 0.351 | 0.005 | 0.364 | Nitric-oxide synthase stimulant | 0.364 0.004 DBMET00507 | DBMET00507 | |
| 0.343 | 0.008 | 0.343 | UDP-glucose 4-epimerase inhibitor | 0.15 0.029 DBMET00507 | ||
| 0.329 | 0.004 | 0.329 | Prostaglandin E2 antagonist | |||
| 0.34 | 0.021 | 0.34 | Non-steroidal antiinflammatory agent | 0.196 0.075 DBMET00507 | ||
| 0.338 | 0.023 | 0.338 | Dual specificity phosphatase inhibitor | |||
| 0.318 | 0.008 | 0.318 | Cystathionine beta-synthase inhibitor | 0.158 0.037 DBMET00507 | ||
| 0.36 | 0.051 | 0.36 | Apoptosis antagonist | 0.337 0.062 DBMET00507 | ||
| 0.353 | 0.055 | 0.353 | 12-Lipoxygenase inhibitor | |||
| 0.304 | 0.017 | 0.304 | Neurotrophic factor enhancer | 0.265 0.031 DBMET00507 | ||
| 0.283 | 0.003 | 0.283 | Lanosterol 14 alpha demethylase inhibitor | 0.133 0.02 DBMET00507 | ||
| 0.292 | 0.012 | 0.305 | Aldehyde dehydrogenase inhibitor | 0.305 0.011 DBMET00507 | DBMET00507 | |
| 0.36 | 0.082 | 0.36 | Calpain 2 inhibitor | 0.322 0.101 DBMET00507 | ||
| 0.273 | 0.004 | 0.273 | HIV-1 integrase (Overall Integration) inhibitor | 0.234 0.006 DBMET00507 | ||
| 0.276 | 0.007 | 0.276 | NADH dehydrogenase inhibitor | 0.199 0.01 DBMET00507 | ||
| 0.307 | 0.041 | 0.309 | DNA synthesis inhibitor | 0.309 0.041 DBMET00507 | DBMET00507 | |
| 0.272 | 0.008 | 0.272 | Mannose-6-phosphate isomerase inhibitor | 0.179 0.043 DBMET00507 | ||
| 0.289 | 0.027 | 0.289 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.273 0.033 DBMET00507 | ||
| 0.307 | 0.045 | 0.345 | Interleukin agonist | 0.345 0.03 DBMET00507 | DBMET00507 | |
| 0.272 | 0.012 | 0.272 | Cell wall synthesis inhibitor | 0.191 0.034 DBMET00507 | ||
| 0.261 | 0.004 | 0.261 | Sphingosine 1-phosphate receptor 4 antagonist | 0.13 0.056 DBMET00507 | ||
| 0.248 | 0.004 | 0.248 | Glutamate release inhibitor | 0.092 0.057 DBMET00507 | ||
| 0.327 | 0.084 | 0.327 | Transcription factor NF kappa B inhibitor | 0.251 0.127 DBMET00507 | ||
| 0.345 | 0.102 | 0.523 | Histamine release inhibitor | 0.523 0.022 DBMET00507 | DBMET00507 | |
| 0.247 | 0.009 | 0.334 | Histidine decarboxylase inhibitor | 0.334 0.005 DBMET00507 | DBMET00507 | |
| 0.278 | 0.039 | 0.278 | Anesthetic general | 0.175 0.091 DBMET00507 | ||
| 0.279 | 0.041 | 0.624 | Peroxidase inhibitor | 0.624 0.004 DBMET00507 | DBMET00507 | |
| 0.238 | 0.005 | 0.238 | Prostaglandin antagonist | 0.057 0.034 DBMET00507 | ||
| 0.245 | 0.016 | 0.245 | Cell adhesion inhibitor | 0.244 0.016 DBMET00507 | ||
| 0.304 | 0.077 | 0.304 | Streptokinase A inhibitor | |||
| 0.273 | 0.049 | 0.526 | Tyrosine 3 hydroxylase inhibitor | 0.526 0.004 DBMET00507 | DBMET00507 | |
| 0.223 | 0.003 | 0.223 | Glutamate (mGluR3) antagonist | 0.038 0.024 DBMET00507 | ||
| 0.225 | 0.008 | 0.245 | Triose-phosphate isomerase inhibitor | 0.245 0.007 DBMET00507 | DBMET00507 | |
| 0.22 | 0.004 | 0.22 | Phosphorylase inhibitor | 0.203 0.005 DBMET00507 | ||
| 0.357 | 0.143 | 0.489 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.489 0.039 DBMET00507 | DBMET00507 | |
| 0.35 | 0.136 | 0.35 | Alpha-glucosidase inhibitor | |||
| 0.226 | 0.015 | 0.226 | Carbonic anhydrase XV inhibitor | 0.109 0.056 DBMET00507 | ||
| 0.231 | 0.022 | 0.231 | Hexokinase inhibitor | 0.162 0.066 DBMET00507 | ||
| 0.225 | 0.017 | 0.351 | Ferrochelatase inhibitor | 0.351 0.005 DBMET00507 | DBMET00507 | |
| 0.239 | 0.032 | 0.239 | 3C-like protease (Human coronavirus) inhibitor | 0.198 0.053 DBMET00507 | ||
| 0.209 | 0.003 | 0.209 | Ca2+-transporting ATPase inhibitor | 0.156 0.031 DBMET00507 | ||
| 0.221 | 0.015 | 0.221 | MAP kinase 3 inhibitor | |||
| 0.266 | 0.062 | 0.381 | Gastrin inhibitor | 0.381 0.005 DBMET00507 | DBMET00507 | |
| 0.214 | 0.01 | 0.336 | Porphobilinogen synthase inhibitor | 0.336 0.005 DBMET00507 | DBMET00507 | |
| 0.321 | 0.12 | 0.321 | Antibacterial | 0.243 0.184 DBMET00507 | ||
| 0.21 | 0.013 | 0.21 | Potassium channel (Ca-activated) activator | 0.164 0.024 DBMET00507 | ||
| 0.253 | 0.056 | 0.253 | Anticonvulsant | 0.167 0.11 DBMET00507 | ||
| 0.252 | 0.058 | 0.252 | Psychostimulant | 0.201 0.079 DBMET00507 | ||
| 0.265 | 0.073 | 0.265 | Transcription factor STAT3 inhibitor | 0.233 0.098 DBMET00507 | ||
| 0.215 | 0.027 | 0.215 | ATPase inhibitor | 0.2 0.037 DBMET00507 | ||
| 0.218 | 0.034 | 0.355 | Phospholipase C inhibitor | 0.355 0.014 DBMET00507 | DBMET00507 | |
| 0.256 | 0.076 | 0.256 | Aryl hydrocarbon receptor agonist | |||
| 0.182 | 0.005 | 0.182 | Sphingosine 1-phosphate receptor 4 agonist | 0.169 0.006 DBMET00507 | ||
| 0.204 | 0.029 | 0.204 | Arachidonic acid antagonist | 0.194 0.039 DBMET00507 | ||
| 0.195 | 0.021 | 0.519 | GABA C receptor agonist | 0.519 0.004 DBMET00507 | DBMET00507 | |
| 0.205 | 0.033 | 0.205 | NADPH oxidase inhibitor | 0.127 0.074 DBMET00507 | ||
| 0.207 | 0.039 | 0.207 | Protein kinase stimulant | 0.128 0.085 DBMET00507 | ||
| 0.171 | 0.006 | 0.171 | Autotaxin inhibitor | |||
| 0.179 | 0.015 | 0.179 | AMP-activated protein kinase stimulant | 0.123 0.046 DBMET00507 | ||
| 0.25 | 0.086 | 0.25 | Transcription factor STAT inhibitor | 0.215 0.118 DBMET00507 | ||
| 0.177 | 0.013 | 0.177 | Aminoacyl-tRNA synthetase inhibitor | 0.088 0.063 DBMET00507 | ||
| 0.175 | 0.012 | 0.223 | Electrolyte absorption antagonist | 0.223 0.006 DBMET00507 | DBMET00507 | |
| 0.197 | 0.036 | 0.197 | Nav1.2 sodium channel blocker | 0.147 0.059 DBMET00507 | ||
| 0.201 | 0.04 | 0.201 | Interferon gamma antagonist | 0.138 0.095 DBMET00507 | ||
| 0.27 | 0.111 | 0.474 | Antithrombotic | 0.474 0.033 DBMET00507 | DBMET00507 | |
| 0.272 | 0.116 | 0.272 | Prostaglandin dehydrogenase inhibitor | |||
| 0.17 | 0.017 | 0.17 | Creatine kinase inhibitor | 0.155 0.022 DBMET00507 | ||
| 0.182 | 0.032 | 0.182 | Cholesterol synthesis inhibitor | 0.154 0.042 DBMET00507 | ||
| 0.187 | 0.038 | 0.225 | Hemostatic | 0.225 0.025 DBMET00507 | DBMET00507 | |
| 0.162 | 0.013 | 0.162 | Cell adhesion molecule inhibitor | 0.161 0.013 DBMET00507 | ||
| 0.155 | 0.007 | 0.165 | NMDA receptor agonist | 0.165 0.006 DBMET00507 | DBMET00507 | |
| 0.171 | 0.025 | 0.171 | Pregnane X receptor agonist | |||
| 0.18 | 0.037 | 0.18 | CF transmembrane conductance regulator agonist | 0.171 0.046 DBMET00507 | ||
| 0.174 | 0.031 | 0.184 | Adenylate cyclase stimulant | 0.184 0.023 DBMET00507 | DBMET00507 | |
| 0.166 | 0.024 | 0.166 | Sphingosine 1-phosphate receptor 2 antagonist | 0.153 0.037 DBMET00507 | ||
| 0.159 | 0.017 | 0.159 | DOPA decarboxylase inhibitor | 0.14 0.027 DBMET00507 | ||
| 0.224 | 0.083 | 0.224 | Neuropeptide Y2 antagonist | 0.209 0.104 DBMET00507 | ||
| 0.144 | 0.004 | 0.144 | Glutamate (mGluR6) antagonist | 0.09 0.015 DBMET00507 | ||
| 0.143 | 0.003 | 0.143 | CC chemokine 4 receptor antagonist | |||
| 0.163 | 0.024 | 0.163 | Carbonic anhydrase III inhibitor | 0.133 0.036 DBMET00507 | ||
| 0.171 | 0.033 | 0.171 | Cyclooxygenase 3 inhibitor | 0.158 0.042 DBMET00507 | ||
| 0.162 | 0.025 | 0.162 | Heat shock protein 70 antagonist | 0.146 0.055 DBMET00507 | ||
| 0.226 | 0.088 | 0.251 | Calpain inhibitor | 0.251 0.064 DBMET00507 | DBMET00507 | |
| 0.16 | 0.024 | 0.217 | Catalase inhibitor | 0.217 0.012 DBMET00507 | DBMET00507 | |
| 0.204 | 0.069 | 0.267 | Insulin sensitizer | 0.267 0.026 DBMET00507 | DBMET00507 | |
| 0.18 | 0.047 | 0.18 | MAO inhibitor | |||
| 0.137 | 0.005 | 0.137 | NMDA receptor glycine site agonist | 0.129 0.007 DBMET00507 | ||
| 0.168 | 0.036 | 0.168 | Sphingosine 1-phosphate receptor 5 antagonist | 0.154 0.055 DBMET00507 | ||
| 0.177 | 0.045 | 0.289 | GABA C receptor rho-2 antagonist | 0.289 0.006 DBMET00507 | DBMET00507 | |
| 0.2 | 0.069 | 0.268 | DNA methyltransferase I inhibitor | 0.268 0.039 DBMET00507 | DBMET00507 | |
| 0.168 | 0.036 | 0.168 | Farnesoid X receptor antagonist | 0.151 0.051 DBMET00507 | ||
| 0.257 | 0.128 | 0.309 | Vasodilator, coronary | 0.309 0.08 DBMET00507 | DBMET00507 | |
| 0.132 | 0.004 | 0.132 | Vanilloid 4 agonist | 0.092 0.024 DBMET00507 | ||
| 0.131 | 0.004 | 0.131 | Prostaglandin EP1 antagonist | |||
| 0.265 | 0.138 | 0.265 | Immunosuppressant | 0.24 0.157 DBMET00507 | ||
| 0.145 | 0.019 | 0.145 | Phosphofructokinase-1 inhibitor | 0.135 0.021 DBMET00507 | ||
| 0.195 | 0.071 | 0.195 | 5 Hydroxytryptamine 3E antagonist | 0.18 0.105 DBMET00507 | ||
| 0.149 | 0.025 | 0.149 | Sphingomyelinase inhibitor | 0.117 0.043 DBMET00507 | ||
| 0.134 | 0.011 | 0.134 | GABA aminotransferase inhibitor | 0.134 0.011 DBMET00507 | ||
| 0.154 | 0.031 | 0.154 | Interleukin 8 antagonist | 0.103 0.09 DBMET00507 | ||
| 0.201 | 0.079 | 0.26 | DNA methylase inhibitor | 0.26 0.043 DBMET00507 | DBMET00507 | |
| 0.146 | 0.025 | 0.146 | Uric acid excretion stimulant | |||
| 0.125 | 0.005 | 0.125 | Sphingosine kinase 2 inhibitor | |||
| 0.218 | 0.099 | 0.508 | Superoxide dismutase inhibitor | 0.508 0.012 DBMET00507 | DBMET00507 | |
| 0.168 | 0.049 | 0.168 | Alkaline phosphatase inhibitor | 0.143 0.065 DBMET00507 | ||
| 0.14 | 0.022 | 0.14 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.077 0.054 DBMET00507 | ||
| 0.134 | 0.016 | 0.134 | Interleukin 5 antagonist | |||
| 0.277 | 0.16 | 0.277 | Analgesic | |||
| 0.153 | 0.036 | 0.153 | MAO B inhibitor | |||
| 0.127 | 0.011 | 0.127 | D-Ala-D-Ala ligase inhibitor | 0.111 0.019 DBMET00507 | ||
| 0.18 | 0.064 | 0.18 | Antipruritic | |||
| 0.129 | 0.014 | 0.129 | Potassium channel large-conductance Ca-activated activator | 0.073 0.041 DBMET00507 | ||
| 0.144 | 0.029 | 0.254 | Adenylate kinase inhibitor | 0.254 0.01 DBMET00507 | DBMET00507 | |
| 0.161 | 0.047 | 0.161 | Sodium channel (voltage-gated) blocker | |||
| 0.144 | 0.031 | 0.144 | Nav1.5 sodium channel blocker | |||
| 0.132 | 0.022 | 0.132 | CYP2A6 inhibitor | |||
| 0.132 | 0.022 | 0.132 | Glutamate receptor agonist | |||
| 0.143 | 0.034 | 0.276 | GABA C receptor antagonist | 0.276 0.005 DBMET00507 | DBMET00507 | |
| 0.121 | 0.012 | 0.121 | Sphingosine 1-phosphate receptor antagonist | 0.11 0.016 DBMET00507 | ||
| 0.117 | 0.008 | 0.117 | GABA B receptor agonist | 0.111 0.01 DBMET00507 | ||
| 0.112 | 0.005 | 0.112 | Liver X receptor beta agonist | |||
| 0.138 | 0.031 | 0.138 | Beta glucuronidase inhibitor | |||
| 0.168 | 0.064 | 0.168 | Protein-tyrosine phosphatase inhibitor | 0.149 0.079 DBMET00507 | ||
| 0.122 | 0.018 | 0.122 | Bile acid receptor antagonist | 0.119 0.021 DBMET00507 | ||
| 0.166 | 0.062 | 0.166 | Melanin inhibitor | 0.161 0.068 DBMET00507 | ||
| 0.133 | 0.029 | 0.133 | Anabolic | 0.126 0.034 DBMET00507 | ||
| 0.122 | 0.019 | 0.122 | Myeloperoxidase inhibitor | |||
| 0.108 | 0.005 | 0.108 | MDM2 inhibitor | 0.072 0.033 DBMET00507 | ||
| 0.133 | 0.03 | 0.133 | NMDA receptor antagonist | 0.091 0.053 DBMET00507 | ||
| 0.121 | 0.018 | 0.121 | Glycine receptor antagonist | 0.118 0.019 DBMET00507 | ||
| 0.11 | 0.007 | 0.11 | Sphingosine 1-phosphate receptor 1 antagonist | 0.081 0.014 DBMET00507 | ||
| 0.239 | 0.136 | 0.239 | Vasodilator, peripheral | 0.224 0.149 DBMET00507 | ||
| 0.134 | 0.033 | 0.142 | Urease inhibitor | 0.142 0.027 DBMET00507 | DBMET00507 | |
| 0.12 | 0.019 | 0.12 | Prostaglandin-E synthase inhibitor | 0.072 0.047 DBMET00507 | ||
| 0.113 | 0.013 | 0.113 | Cannabinoid CB1 receptor antagonist | |||
| 0.22 | 0.121 | 0.22 | Lipoxygenase inhibitor | |||
| 0.105 | 0.007 | 0.105 | Exportin-1 inhibitor | 0.069 0.045 DBMET00507 | ||
| 0.209 | 0.112 | 0.209 | Spasmolytic | 0.191 0.128 DBMET00507 | ||
| 0.21 | 0.114 | 0.345 | Immunostimulant | 0.345 0.066 DBMET00507 | DBMET00507 | |
| 0.148 | 0.054 | 0.234 | Toll-Like receptor 2 antagonist | 0.234 0.012 DBMET00507 | DBMET00507 | |
| 0.11 | 0.016 | 0.178 | Biliverdin reductase inhibitor | 0.178 0.007 DBMET00507 | DBMET00507 | |
| 0.111 | 0.018 | 0.127 | Carbamoyl phosphate synthetase inhibitor | 0.127 0.014 DBMET00507 | DBMET00507 | |
| 0.097 | 0.003 | 0.097 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.113 | 0.019 | 0.113 | Leukotriene synthesis inhibitor | |||
| 0.097 | 0.004 | 0.097 | LFA antagonist | 0.081 0.004 DBMET00507 | ||
| 0.117 | 0.024 | 0.186 | Glutathione S-transferase inhibitor | 0.186 0.007 DBMET00507 | DBMET00507 | |
| 0.116 | 0.027 | 0.116 | Adrenaline agonist | 0.088 0.047 DBMET00507 | ||
| 0.113 | 0.024 | 0.113 | Cannabinoid receptor antagonist | |||
| 0.15 | 0.06 | 0.15 | MAP3K9 inhibitor | |||
| 0.102 | 0.014 | 0.102 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.077 0.022 DBMET00507 | ||
| 0.117 | 0.03 | 0.117 | Carbonic anhydrase VI inhibitor | 0.116 0.031 DBMET00507 | ||
| 0.14 | 0.054 | 0.154 | Cathepsin H inhibitor | 0.154 0.043 DBMET00507 | DBMET00507 | |
| 0.134 | 0.049 | 0.134 | DNA repair enzyme inhibitor | 0.111 0.092 DBMET00507 | ||
| 0.11 | 0.026 | 0.228 | Glutamate dehydrogenase inhibitor | 0.228 0.008 DBMET00507 | DBMET00507 | |
| 0.098 | 0.014 | 0.098 | Aryl hydrocarbon receptor antagonist | |||
| 0.09 | 0.008 | 0.09 | Phosphoglycerate kinase inhibitor | |||
| 0.099 | 0.017 | 0.099 | Purinergic P2X1 antagonist | 0.087 0.021 DBMET00507 | ||
| 0.085 | 0.004 | 0.085 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.048 0.018 DBMET00507 | ||
| 0.16 | 0.079 | 0.205 | Neurotensin receptor agonist | 0.205 0.032 DBMET00507 | DBMET00507 | |
| 0.125 | 0.045 | 0.125 | Xanthine oxidase inhibitor | 0.087 0.077 DBMET00507 | ||
| 0.139 | 0.059 | 0.139 | Glutamate receptor antagonist | |||
| 0.094 | 0.013 | 0.094 | Thromboxane antagonist | 0.067 0.028 DBMET00507 | ||
| 0.136 | 0.056 | 0.167 | Vanilloid 1 agonist | 0.167 0.025 DBMET00507 | DBMET00507 | |
| 0.091 | 0.012 | 0.091 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.094 | 0.016 | 0.094 | Beta 3 adrenoreceptor antagonist | 0.064 0.046 DBMET00507 | ||
| 0.109 | 0.031 | 0.109 | Bromodomain-containing protein 2 inhibitor | |||
| 0.11 | 0.033 | 0.11 | Carbonic anhydrase XIII inhibitor | 0.076 0.053 DBMET00507 | ||
| 0.082 | 0.005 | 0.082 | Pregnane X receptor antagonist | |||
| 0.118 | 0.042 | 0.268 | GABA C receptor rho-1 antagonist | 0.268 0.004 DBMET00507 | DBMET00507 | |
| 0.079 | 0.004 | 0.079 | ATP citrate lysase inhibitor | |||
| 0.078 | 0.003 | 0.078 | CF transmembrane conductance regulator antagonist | |||
| 0.082 | 0.008 | 0.082 | Glucose-6-phosphate isomerase inhibitor | 0.074 0.01 DBMET00507 | ||
| 0.078 | 0.004 | 0.078 | Sodium/glucose cotransporter inhibitor | |||
| 0.103 | 0.029 | 0.103 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.112 | 0.038 | 0.112 | Androgen antagonist | |||
| 0.077 | 0.003 | 0.077 | Ceramide glucosyltransferase inhibitor | 0.044 0.012 DBMET00507 | ||
| 0.134 | 0.06 | 0.134 | Nav1.3 sodium channel blocker | 0.119 0.075 DBMET00507 | ||
| 0.091 | 0.017 | 0.091 | Cannabinoid CB2 receptor antagonist | |||
| 0.086 | 0.013 | 0.086 | Sphingosine kinase inhibitor | 0.054 0.05 DBMET00507 | ||
| 0.135 | 0.062 | 0.135 | Antibacterial (Helicobacter pylori) | 0.111 0.095 DBMET00507 | ||
| 0.114 | 0.041 | 0.114 | MAP kinase kinase 1 inhibitor | |||
| 0.099 | 0.026 | 0.253 | Phenylalanine 4-hydroxylase inhibitor | 0.253 0.005 DBMET00507 | DBMET00507 | |
| 0.099 | 0.026 | 0.099 | Benzodiazepine agonist | |||
| 0.092 | 0.02 | 0.163 | Phospholipase D inhibitor | 0.163 0.002 DBMET00507 | DBMET00507 | |
| 0.117 | 0.047 | 0.117 | Toll-Like receptor 4 antagonist | |||
| 0.159 | 0.089 | 0.159 | Tumour necrosis factor antagonist | |||
| 0.293 | 0.222 | 0.293 | Antiinflammatory | |||
| 0.137 | 0.067 | 0.137 | Sodium channel blocker | |||
| 0.084 | 0.014 | 0.084 | Glucosylceramidase inhibitor | |||
| 0.098 | 0.028 | 0.098 | CDC25A inhibitor | |||
| 0.094 | 0.024 | 0.112 | Glycine receptor agonist | 0.112 0.015 DBMET00507 | DBMET00507 | |
| 0.075 | 0.006 | 0.075 | Farnesoid X receptor agonist | 0.035 0.03 DBMET00507 | ||
| 0.074 | 0.004 | 0.074 | Liver X receptor beta antagonist | |||
| 0.073 | 0.005 | 0.082 | Integrin alpha2 antagonist | 0.082 0.004 DBMET00507 | DBMET00507 | |
| 0.081 | 0.013 | 0.081 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.075 | 0.007 | 0.075 | Glutamate (mGluR group II) antagonist | |||
| 0.101 | 0.033 | 0.132 | Granulocyte macrophage colony stimulating factor agonist | 0.132 0.01 DBMET00507 | DBMET00507 | |
| 0.128 | 0.061 | 0.276 | Adenylate cyclase inhibitor | 0.276 0.016 DBMET00507 | DBMET00507 | |
| 0.146 | 0.079 | 0.146 | Cytidine deaminase inhibitor | |||
| 0.21 | 0.143 | 0.394 | Insulysin inhibitor | 0.394 0.023 DBMET00507 | DBMET00507 | |
| 0.07 | 0.004 | 0.07 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.12 | 0.054 | 0.264 | Mucolytic | 0.264 0.005 DBMET00507 | DBMET00507 | |
| 0.096 | 0.03 | 0.169 | Estrogen-related receptor beta agonist | 0.169 0.003 DBMET00507 | DBMET00507 | |
| 0.071 | 0.006 | 0.071 | Aggrecanase 1 inhibitor | |||
| 0.114 | 0.049 | 0.114 | Bronchodilator | |||
| 0.085 | 0.02 | 0.14 | Acyl-CoA dehydrogenase inhibitor | 0.14 0.01 DBMET00507 | DBMET00507 | |
| 0.078 | 0.014 | 0.078 | NMDA receptor subunit 3B antagonist | 0.052 0.024 DBMET00507 | ||
| 0.122 | 0.058 | 0.171 | Caspase 3 inhibitor | 0.171 0.017 DBMET00507 | DBMET00507 | |
| 0.094 | 0.031 | 0.094 | Cyclin B3 inhibitor | |||
| 0.068 | 0.004 | 0.068 | Heme oxygenase inhibitor | |||
| 0.074 | 0.012 | 0.074 | Liver X receptor agonist | |||
| 0.076 | 0.013 | 0.076 | Dihydroorotate oxidase inhibitor | 0.054 0.041 DBMET00507 | ||
| 0.117 | 0.054 | 0.248 | Aminopeptidase B inhibitor | 0.248 0.013 DBMET00507 | DBMET00507 | |
| 0.076 | 0.014 | 0.086 | Sphingosine 1-phosphate receptor 5 agonist | 0.086 0.011 DBMET00507 | DBMET00507 | |
| 0.075 | 0.013 | 0.075 | Beta 2 adrenoreceptor agonist | 0.069 0.02 DBMET00507 | ||
| 0.096 | 0.034 | 0.147 | Cathepsin G inhibitor | 0.147 0.022 DBMET00507 | DBMET00507 | |
| 0.07 | 0.009 | 0.07 | Liver X receptor alpha agonist | |||
| 0.091 | 0.03 | 0.091 | Carbonic anhydrase V inhibitor | 0.082 0.034 DBMET00507 | ||
| 0.083 | 0.022 | 0.083 | Androgen agonist | 0.054 0.049 DBMET00507 | ||
| 0.078 | 0.017 | 0.078 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.076 | 0.015 | 0.179 | Aconitate hydratase inhibitor | 0.179 0.004 DBMET00507 | DBMET00507 | |
| 0.068 | 0.008 | 0.068 | Prostaglandin agonist | |||
| 0.071 | 0.011 | 0.071 | Potassium channel (Inward rectifier) activator | |||
| 0.082 | 0.024 | 0.082 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.06 0.04 DBMET00507 | ||
| 0.174 | 0.115 | 0.223 | Hypolipemic | 0.223 0.08 DBMET00507 | DBMET00507 | |
| 0.212 | 0.153 | 0.212 | Caspase 3 stimulant | |||
| 0.077 | 0.018 | 0.077 | Calcium channel P-type blocker | |||
| 0.077 | 0.019 | 0.077 | Botulinum neurotoxin type A inhibitor | 0.073 0.022 DBMET00507 | ||
| 0.106 | 0.048 | 0.142 | Glutamate (mGluR7) agonist | 0.142 0.015 DBMET00507 | DBMET00507 | |
| 0.068 | 0.01 | 0.068 | Potassium channel (ATP-sensitive) activator | |||
| 0.071 | 0.014 | 0.071 | NMDA receptor subunit 3A antagonist | 0.049 0.02 DBMET00507 | ||
| 0.071 | 0.014 | 0.071 | Adenine nucleotide translocase inhibitor | 0.067 0.018 DBMET00507 | ||
| 0.064 | 0.007 | 0.148 | Glucagon receptor antagonist | 0.148 0.004 DBMET00507 | DBMET00507 | |
| 0.117 | 0.061 | 0.147 | Photosensitizer | 0.147 0.033 DBMET00507 | DBMET00507 | |
| 0.06 | 0.004 | 0.06 | Integrin alpha2beta1 antagonist | 0.04 0.006 DBMET00507 | ||
| 0.085 | 0.029 | 0.085 | Purinergic P2 antagonist | |||
| 0.08 | 0.025 | 0.08 | Dopamine uptake inhibitor | |||
| 0.066 | 0.012 | 0.066 | Urate transporter 1 inhibitor | |||
| 0.086 | 0.032 | 0.086 | Carbonic anhydrase VA inhibitor | 0.084 0.034 DBMET00507 | ||
| 0.093 | 0.039 | 0.093 | Macrophage migration inhibitory factor inhibitor | |||
| 0.096 | 0.043 | 0.096 | Transcription factor NF kappa B stimulant | |||
| 0.078 | 0.025 | 0.191 | Alcohol oxidase inhibitor | 0.191 0.007 DBMET00507 | DBMET00507 | |
| 0.09 | 0.037 | 0.09 | NMDA 2 receptor antagonist | 0.071 0.05 DBMET00507 | ||
| 0.091 | 0.04 | 0.091 | Na+ K+ transporting ATPase inhibitor | |||
| 0.064 | 0.012 | 0.064 | Thymidine kinase inhibitor | 0.048 0.02 DBMET00507 | ||
| 0.069 | 0.018 | 0.111 | Alpha-mannosidase inhibitor | 0.111 0.005 DBMET00507 | DBMET00507 | |
| 0.137 | 0.086 | 0.137 | Neuropeptide Y1 antagonist | |||
| 0.075 | 0.025 | 0.075 | Carbonic anhydrase VB inhibitor | 0.058 0.037 DBMET00507 | ||
| 0.086 | 0.036 | 0.086 | Adenosine A3 receptor antagonist | |||
| 0.076 | 0.027 | 0.076 | Xanthine dehydrogenase inhibitor | |||
| 0.055 | 0.007 | 0.055 | Free fatty acid receptor 1 antagonist | |||
| 0.058 | 0.01 | 0.058 | Nerve growth factor antagonist | |||
| 0.062 | 0.013 | 0.062 | Purinergic P2X4 antagonist | |||
| 0.065 | 0.018 | 0.337 | CD45 antagonist | 0.337 0.004 DBMET00507 | DBMET00507 | |
| 0.072 | 0.025 | 0.072 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.1 | 0.053 | 0.209 | Alcohol dehydrogenase inhibitor | 0.209 0.011 DBMET00507 | DBMET00507 | |
| 0.051 | 0.005 | 0.051 | Prostaglandin E2 agonist | |||
| 0.052 | 0.007 | 0.052 | Uridine phosphorylase inhibitor | 0.026 0.021 DBMET00507 | ||
| 0.063 | 0.018 | 0.076 | Heparanase inhibitor | 0.076 0.008 DBMET00507 | DBMET00507 | |
| 0.101 | 0.056 | 0.177 | Interleukin 1 beta converting enzyme inhibitor | 0.177 0.009 DBMET00507 | DBMET00507 | |
| 0.056 | 0.012 | 0.056 | Sphingosine kinase 1 inhibitor | |||
| 0.114 | 0.07 | 0.114 | Transcription factor STAT6 inhibitor | 0.112 0.075 DBMET00507 | ||
| 0.067 | 0.023 | 0.067 | Thromboxane A2 antagonist | 0.063 0.026 DBMET00507 | ||
| 0.056 | 0.013 | 0.056 | Dihydrofolate reductase inhibitor | 0.048 0.022 DBMET00507 | ||
| 0.075 | 0.032 | 0.075 | CDC25B inhibitor | |||
| 0.057 | 0.015 | 0.057 | Glutamate (mGluR group III) antagonist | 0.045 0.027 DBMET00507 | ||
| 0.149 | 0.107 | 0.149 | Platelet adhesion inhibitor | 0.148 0.108 DBMET00507 | ||
| 0.063 | 0.021 | 0.063 | Purinergic P2X antagonist | |||
| 0.057 | 0.016 | 0.057 | Benzodiazepine antagonist | |||
| 0.047 | 0.006 | 0.047 | Prostaglandin EP2 agonist | 0.021 0.017 DBMET00507 | ||
| 0.078 | 0.037 | 0.099 | Peroxisome proliferator-activated receptor gamma antagonist | 0.099 0.016 DBMET00507 | DBMET00507 | |
| 0.058 | 0.018 | 0.062 | Sphingosine 1-phosphate receptor agonist | 0.062 0.015 DBMET00507 | DBMET00507 | |
| 0.064 | 0.023 | 0.086 | Thromboxane synthase inhibitor | 0.086 0.009 DBMET00507 | DBMET00507 | |
| 0.082 | 0.042 | 0.265 | Glutamate decarboxylase inhibitor | 0.265 0.004 DBMET00507 | DBMET00507 | |
| 0.058 | 0.018 | 0.058 | Dopamine beta hydroxylase inhibitor | |||
| 0.064 | 0.025 | 0.064 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.051 | 0.012 | 0.064 | RNA-directed RNA polymerase inhibitor | 0.064 0.009 DBMET00507 | DBMET00507 | |
| 0.063 | 0.024 | 0.071 | Leukotriene C antagonist | 0.071 0.013 DBMET00507 | DBMET00507 | |
| 0.057 | 0.019 | 0.1 | Mannosidase inhibitor | 0.1 0.006 DBMET00507 | DBMET00507 | |
| 0.071 | 0.033 | 0.092 | Prostaglandin EP2 antagonist | 0.092 0.021 DBMET00507 | DBMET00507 | |
| 0.048 | 0.01 | 0.048 | Liver X receptor antagonist | |||
| 0.075 | 0.038 | 0.075 | Nav1.7 sodium channel blocker | |||
| 0.095 | 0.057 | 0.095 | Protein kinase C zeta inhibitor | |||
| 0.11 | 0.073 | 0.152 | Microtubule formation inhibitor | 0.152 0.037 DBMET00507 | DBMET00507 | |
| 0.046 | 0.009 | 0.046 | Glutamate (mGluR2) antagonist | |||
| 0.165 | 0.128 | 0.165 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.133 | 0.096 | 0.208 | Phospholipase A2 inhibitor | 0.208 0.038 DBMET00507 | DBMET00507 | |
| 0.112 | 0.076 | 0.169 | Alkylator | 0.169 0.037 DBMET00507 | DBMET00507 | |
| 0.054 | 0.018 | 0.054 | Guanylate cyclase inhibitor | 0.04 0.034 DBMET00507 | ||
| 0.14 | 0.105 | 0.14 | Nitric oxide antagonist | |||
| 0.051 | 0.015 | 0.051 | GABA uptake inhibitor | 0.038 0.03 DBMET00507 | ||
| 0.043 | 0.008 | 0.043 | Liver X receptor alpha antagonist | |||
| 0.05 | 0.014 | 0.05 | Purinergic P2X7 antagonist | |||
| 0.079 | 0.043 | 0.201 | Aminopeptidase I inhibitor | 0.201 0.007 DBMET00507 | DBMET00507 | |
| 0.109 | 0.073 | 0.153 | TRPA1 agonist | 0.153 0.029 DBMET00507 | DBMET00507 | |
| 0.045 | 0.009 | 0.045 | Prostaglandin EP4 antagonist | 0.03 0.015 DBMET00507 | ||
| 0.07 | 0.034 | 0.07 | Aromatase inhibitor | |||
| 0.067 | 0.032 | 0.131 | Argininosuccinate synthase inhibitor | 0.131 0.014 DBMET00507 | DBMET00507 | |
| 0.039 | 0.004 | 0.048 | ICAM 1 antagonist | 0.048 0.004 DBMET00507 | DBMET00507 | |
| 0.083 | 0.048 | 0.083 | Interferon agonist | 0.074 0.063 DBMET00507 | ||
| 0.056 | 0.021 | 0.056 | Cholesterol esterase inhibitor | |||
| 0.235 | 0.201 | 0.248 | DNA directed DNA polymerase inhibitor | 0.248 0.193 DBMET00507 | DBMET00507 | |
| 0.048 | 0.014 | 0.062 | Fumarate hydratase inhibitor | 0.062 0.01 DBMET00507 | DBMET00507 | |
| 0.048 | 0.013 | 0.05 | Glutamate (mGluR8) agonist | 0.05 0.012 DBMET00507 | DBMET00507 | |
| 0.047 | 0.012 | 0.047 | VCAM-1 antagonist | 0.047 0.011 DBMET00507 | ||
| 0.046 | 0.012 | 0.047 | VCAM antagonist | 0.047 0.011 DBMET00507 | DBMET00507 | |
| 0.095 | 0.061 | 0.125 | Prolactin inhibitor | 0.125 0.035 DBMET00507 | DBMET00507 | |
| 0.057 | 0.023 | 0.061 | Adenosine deaminase inhibitor | 0.061 0.019 DBMET00507 | DBMET00507 | |
| 0.04 | 0.007 | 0.04 | Thymidine phosphorylase inhibitor | |||
| 0.068 | 0.035 | 0.088 | NMDA 2C receptor antagonist | 0.088 0.021 DBMET00507 | DBMET00507 | |
| 0.038 | 0.006 | 0.038 | Prostaglandin EP4 agonist | |||
| 0.068 | 0.036 | 0.068 | Adrenaline uptake inhibitor | |||
| 0.051 | 0.02 | 0.055 | Glutamate (mGluR4) antagonist | 0.055 0.016 DBMET00507 | DBMET00507 | |
| 0.036 | 0.004 | 0.036 | G-protein-coupled receptor 120 agonist | |||
| 0.068 | 0.037 | 0.068 | Interferon inducer | 0.06 0.053 DBMET00507 | ||
| 0.065 | 0.034 | 0.065 | EphB4 antagonist | |||
| 0.053 | 0.022 | 0.053 | Glutamate (mGluR group III) agonist | 0.044 0.029 DBMET00507 | ||
| 0.086 | 0.055 | 0.086 | mTOR complex 2 inhibitor | |||
| 0.182 | 0.151 | 0.182 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.049 | 0.019 | 0.049 | Beta adrenoreceptor agonist | 0.047 0.025 DBMET00507 | ||
| 0.047 | 0.017 | 0.057 | Kainate receptor agonist | 0.057 0.008 DBMET00507 | DBMET00507 | |
| 0.039 | 0.009 | 0.039 | NMDA receptor glycine site antagonist | 0.024 0.017 DBMET00507 | ||
| 0.128 | 0.098 | 0.128 | Acetylcholine M1 receptor antagonist | |||
| 0.094 | 0.064 | 0.094 | DNA directed RNA polymerase inhibitor | |||
| 0.043 | 0.013 | 0.046 | HCV NS5B polymerase inhibitor | 0.046 0.011 DBMET00507 | DBMET00507 | |
| 0.068 | 0.039 | 0.068 | 5 Hydroxytryptamine 2A agonist | |||
| 0.075 | 0.045 | 0.075 | HIV-1 reverse transcriptase inhibitor | |||
| 0.076 | 0.046 | 0.088 | Potassium channel (Tandem pore domain) blocker | 0.088 0.02 DBMET00507 | DBMET00507 | |
| 0.053 | 0.024 | 0.053 | Carnitine palmitoyltransferase 1B inhibitor | 0.049 0.031 DBMET00507 | ||
| 0.05 | 0.021 | 0.05 | Kainate receptor antagonist | 0.044 0.025 DBMET00507 | ||
| 0.126 | 0.098 | 0.285 | Diuretic | 0.285 0.025 DBMET00507 | DBMET00507 | |
| 0.052 | 0.024 | 0.052 | Secretase gamma inhibitor | |||
| 0.049 | 0.021 | 0.049 | GABA B receptor antagonist | |||
| 0.079 | 0.05 | 0.09 | MAP kinase kinase 7 inhibitor | 0.09 0.024 DBMET00507 | DBMET00507 | |
| 0.09 | 0.062 | 0.09 | Thioredoxin inhibitor | |||
| 0.061 | 0.034 | 0.067 | Beta 1 adrenoreceptor antagonist | 0.067 0.029 DBMET00507 | DBMET00507 | |
| 0.101 | 0.074 | 0.101 | 5 Hydroxytryptamine 3A agonist | |||
| 0.054 | 0.027 | 0.078 | Topoisomerase II beta inhibitor | 0.078 0.014 DBMET00507 | DBMET00507 | |
| 0.064 | 0.037 | 0.064 | Cyclin D1 inhibitor | |||
| 0.065 | 0.038 | 0.081 | Caspase 9 inhibitor | 0.081 0.023 DBMET00507 | DBMET00507 | |
| 0.059 | 0.033 | 0.059 | GABA receptor antagonist | |||
| 0.058 | 0.032 | 0.091 | Epithelial sodium channel blocker | 0.091 0.009 DBMET00507 | DBMET00507 | |
| 0.078 | 0.052 | 0.127 | Keratolytic | 0.127 0.019 DBMET00507 | DBMET00507 | |
| 0.068 | 0.042 | 0.081 | Beta adrenoreceptor antagonist | 0.081 0.026 DBMET00507 | DBMET00507 | |
| 0.034 | 0.009 | 0.042 | Thyroid hormone agonist | 0.042 0.005 DBMET00507 | DBMET00507 | |
| 0.037 | 0.012 | 0.037 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.043 | 0.018 | 0.043 | p53 inhibitor | |||
| 0.039 | 0.014 | 0.039 | Protein kinase (CK2) beta inhibitor | |||
| 0.044 | 0.02 | 0.044 | TRPM8 blocker | |||
| 0.082 | 0.058 | 0.082 | Thioredoxin reductase inhibitor | |||
| 0.043 | 0.02 | 0.043 | Diamine oxidase inhibitor | |||
| 0.061 | 0.037 | 0.083 | Sphingosine 1-phosphate receptor 3 antagonist | 0.083 0.015 DBMET00507 | DBMET00507 | |
| 0.027 | 0.004 | 0.035 | Integrin beta2 antagonist | 0.035 0.004 DBMET00507 | DBMET00507 | |
| 0.032 | 0.009 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.049 | 0.026 | 0.052 | Dihydroorotase inhibitor | 0.052 0.022 DBMET00507 | DBMET00507 | |
| 0.031 | 0.009 | 0.031 | Geranylgeranyltransferase inhibitor | |||
| 0.041 | 0.019 | 0.041 | Vanilloid 3 antagonist | |||
| 0.036 | 0.014 | 0.043 | Glutamate (mGluR3) agonist | 0.043 0.008 DBMET00507 | DBMET00507 | |
| 0.055 | 0.033 | 0.102 | NMDA 2A receptor antagonist | 0.102 0.013 DBMET00507 | DBMET00507 | |
| 0.046 | 0.024 | 0.05 | Sphingosine 1-phosphate receptor 1 agonist | 0.05 0.02 DBMET00507 | DBMET00507 | |
| 0.072 | 0.051 | 0.118 | Epoxide hydrolase inhibitor | 0.118 0.018 DBMET00507 | DBMET00507 | |
| 0.103 | 0.082 | 0.119 | CDK3/cyclin E inhibitor | 0.119 0.057 DBMET00507 | DBMET00507 | |
| 0.065 | 0.044 | 0.065 | Dopamine D1 antagonist | |||
| 0.056 | 0.035 | 0.056 | Toll-Like receptor 8 antagonist | |||
| 0.036 | 0.016 | 0.069 | VLA-4 antagonist | 0.069 0.009 DBMET00507 | DBMET00507 | |
| 0.041 | 0.021 | 0.046 | Leukotriene C4 antagonist | 0.046 0.014 DBMET00507 | DBMET00507 | |
| 0.041 | 0.021 | 0.041 | Potassium channel Kv1.1 blocker | |||
| 0.101 | 0.082 | 0.101 | Anesthetic local | 0.094 0.089 DBMET00507 | ||
| 0.032 | 0.012 | 0.032 | CXC chemokine 2 receptor antagonist | |||
| 0.038 | 0.018 | 0.038 | Glutamate (mGluR4) agonist | |||
| 0.076 | 0.056 | 0.076 | Estrogen receptor alpha antagonist | |||
| 0.038 | 0.019 | 0.038 | Peroxisome proliferator-activated receptor delta agonist | 0.031 0.026 DBMET00507 | ||
| 0.026 | 0.006 | 0.026 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.052 | 0.033 | 0.066 | Lysophosphatidic acid 3 receptor antagonist | 0.066 0.018 DBMET00507 | DBMET00507 | |
| 0.051 | 0.032 | 0.051 | Squalene epoxidase inhibitor | |||
| 0.047 | 0.028 | 0.047 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.113 | 0.096 | 0.113 | Toll-Like receptor antagonist | |||
| 0.054 | 0.036 | 0.054 | GABA A receptor antagonist | |||
| 0.027 | 0.01 | 0.027 | Beta 1 adrenoreceptor agonist | |||
| 0.02 | 0.004 | 0.02 | Thromboxane agonist | |||
| 0.042 | 0.026 | 0.044 | Dopamine D5 agonist | 0.044 0.023 DBMET00507 | DBMET00507 | |
| 0.035 | 0.019 | 0.035 | Potassium channel small-conductance Ca-activated activator | |||
| 0.101 | 0.085 | 0.101 | Acetylcholine release stimulant | 0.1 0.088 DBMET00507 | ||
| 0.063 | 0.047 | 0.063 | Kallikrein 7 inhibitor | |||
| 0.044 | 0.028 | 0.044 | Alpha 1L adrenoreceptor agonist | |||
| 0.084 | 0.069 | 0.084 | Potassium channel activator | |||
| 0.055 | 0.039 | 0.055 | Immunoglobulin Fc receptor antagonist | 0.054 0.043 DBMET00507 | ||
| 0.033 | 0.018 | 0.033 | Prostaglandin EP3 antagonist | |||
| 0.047 | 0.032 | 0.126 | Thymidylate synthase inhibitor | 0.126 0.004 DBMET00507 | DBMET00507 | |
| 0.081 | 0.066 | 0.081 | Histamine N-methyltransferase inhibitor | |||
| 0.036 | 0.023 | 0.094 | Tryptophan 5 hydroxylase inhibitor | 0.094 0.002 DBMET00507 | DBMET00507 | |
| 0.034 | 0.02 | 0.034 | Bradykinin B2 receptor antagonist | |||
| 0.039 | 0.026 | 0.039 | 5 Hydroxytryptamine 2B agonist | |||
| 0.04 | 0.027 | 0.072 | Glucagon-like peptide 1 receptor antagonist | 0.072 0.006 DBMET00507 | DBMET00507 | |
| 0.088 | 0.075 | 0.088 | Ephrin antagonist | |||
| 0.041 | 0.028 | 0.041 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.045 | 0.032 | 0.045 | Glutamate (mGluR5) agonist | |||
| 0.027 | 0.014 | 0.027 | Complement factor 1s inhibitor | |||
| 0.042 | 0.029 | 0.045 | Angiotensin AT1 receptor antagonist | 0.045 0.024 DBMET00507 | DBMET00507 | |
| 0.06 | 0.048 | 0.06 | Phosphodiesterase 1C inhibitor | |||
| 0.037 | 0.025 | 0.059 | Arginase inhibitor | 0.059 0.011 DBMET00507 | DBMET00507 | |
| 0.048 | 0.035 | 0.067 | Carbonic anhydrase XIV inhibitor | 0.067 0.021 DBMET00507 | DBMET00507 | |
| 0.02 | 0.008 | 0.02 | CC chemokine 9 receptor antagonist | |||
| 0.08 | 0.068 | 0.127 | Ornithine decarboxylase inhibitor | 0.127 0.021 DBMET00507 | DBMET00507 | |
| 0.034 | 0.022 | 0.048 | Prostacyclin antagonist | 0.048 0.014 DBMET00507 | DBMET00507 | |
| 0.028 | 0.016 | 0.028 | Hedgehog signaling activator | |||
| 0.021 | 0.009 | 0.021 | Alpha 2b adrenoreceptor agonist | |||
| 0.037 | 0.026 | 0.039 | Delayed rectifier potassium channel blocker | 0.039 0.023 DBMET00507 | DBMET00507 | |
| 0.035 | 0.023 | 0.035 | Carnitine palmitoyltransferase 1 inhibitor | 0.033 0.026 DBMET00507 | ||
| 0.034 | 0.023 | 0.034 | Carnitine palmitoyltransferase inhibitor | 0.034 0.024 DBMET00507 | ||
| 0.08 | 0.068 | 0.113 | T cell inhibitor | 0.113 0.016 DBMET00507 | DBMET00507 | |
| 0.136 | 0.125 | 0.197 | Hepatoprotectant | 0.197 0.067 DBMET00507 | DBMET00507 | |
| 0.046 | 0.035 | 0.046 | Glutamate (mGluR group I) agonist | |||
| 0.017 | 0.006 | 0.017 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.123 | 0.112 | 0.185 | Thiol protease inhibitor | 0.185 0.046 DBMET00507 | DBMET00507 | |
| 0.043 | 0.032 | 0.056 | Geranyltranstransferase inhibitor | 0.056 0.017 DBMET00507 | DBMET00507 | |
| 0.018 | 0.007 | 0.02 | Thromboxane A2 agonist | 0.02 0.005 DBMET00507 | DBMET00507 | |
| 0.05 | 0.039 | 0.128 | Ornithine carbamoyltransferase inhibitor | 0.128 0.012 DBMET00507 | DBMET00507 | |
| 0.023 | 0.013 | 0.035 | Integrin alpha4beta7 antagonist | 0.035 0.007 DBMET00507 | DBMET00507 | |
| 0.055 | 0.045 | 0.055 | Dopamine D4 antagonist | |||
| 0.045 | 0.035 | 0.1 | Antimetabolite | 0.1 0.016 DBMET00507 | DBMET00507 | |
| 0.091 | 0.08 | 0.251 | Expectorant | 0.251 0.013 DBMET00507 | DBMET00507 | |
| 0.034 | 0.024 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.049 | 0.039 | 0.049 | 5 Hydroxytryptamine 2 agonist | |||
| 0.035 | 0.025 | 0.037 | Kainate receptor 2 antagonist | 0.037 0.024 DBMET00507 | DBMET00507 | |
| 0.114 | 0.106 | 0.114 | Nav1.6 sodium channel blocker | |||
| 0.032 | 0.024 | 0.033 | Sirtuin 2 inhibitor | 0.033 0.023 DBMET00507 | DBMET00507 | |
| 0.022 | 0.015 | 0.022 | Aggrecanase 2 inhibitor | |||
| 0.028 | 0.021 | 0.033 | Purinergic P2Y15 antagonist | 0.033 0.012 DBMET00507 | DBMET00507 | |
| 0.059 | 0.052 | 0.069 | Leukotriene antagonist | 0.069 0.041 DBMET00507 | DBMET00507 | |
| 0.046 | 0.04 | 0.046 | Cytokine production stimulant | |||
| 0.025 | 0.019 | 0.025 | Vanilloid 2 agonist | |||
| 0.066 | 0.06 | 0.066 | Vanilloid antagonist | |||
| 0.149 | 0.143 | 0.157 | Growth factor agonist | 0.157 0.127 DBMET00507 | DBMET00507 | |
| 0.067 | 0.061 | 0.067 | Nav1.8 sodium channel blocker | |||
| 0.026 | 0.02 | 0.026 | Nicotinic acid receptor 2 antagonist | |||
| 0.014 | 0.008 | 0.018 | Integrin alphaLbeta2 antagonist | 0.018 0.005 DBMET00507 | DBMET00507 | |
| 0.03 | 0.024 | 0.03 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.02 | 0.015 | 0.02 | Imidazoline I1 receptor antagonist | |||
| 0.017 | 0.012 | 0.017 | Telomerase stimulant | |||
| 0.024 | 0.019 | 0.035 | Prostaglandin H2 antagonist | 0.035 0.009 DBMET00507 | DBMET00507 | |
| 0.022 | 0.017 | 0.022 | Prostaglandin F2 alpha agonist | |||
| 0.089 | 0.084 | 0.139 | Monophenol monooxygenase inhibitor | 0.139 0.052 DBMET00507 | DBMET00507 | |
| 0.042 | 0.038 | 0.079 | Adenylate cyclase 1 inhibitor | 0.079 0.008 DBMET00507 | DBMET00507 | |
| 0.094 | 0.089 | 0.095 | Protein kinase C gamma inhibitor | 0.095 0.087 DBMET00507 | DBMET00507 | |
| 0.027 | 0.023 | 0.027 | Estrogen-related receptor gamma antagonist | |||
| 0.059 | 0.055 | 0.085 | Protease 3C (Human rhinovirus) inhibitor | 0.085 0.023 DBMET00507 | DBMET00507 | |
| 0.034 | 0.03 | 0.038 | Glutamate (mGluR8) antagonist | 0.038 0.021 DBMET00507 | DBMET00507 | |
| 0.019 | 0.015 | 0.028 | Integrin beta7 antagonist | 0.028 0.01 DBMET00507 | DBMET00507 | |
| 0.021 | 0.017 | 0.021 | Prostaglandin D2 antagonist | |||
| 0.017 | 0.014 | 0.017 | Cyclin T1 inhibitor | |||
| 0.032 | 0.029 | 0.034 | Angiotensin II receptor antagonist | 0.034 0.024 DBMET00507 | DBMET00507 | |
| 0.022 | 0.019 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.082 | 0.08 | 0.082 | Protein kinase (CK2) inhibitor | |||
| 0.021 | 0.019 | 0.021 | Isoleucine-tRNA ligase inhibitor | |||
| 0.061 | 0.059 | 0.061 | Potassium channel (ATP-sensitive) blocker | |||
| 0.028 | 0.026 | 0.028 | Cyclophilin A inhibitor | |||
| 0.008 | 0.007 | 0.011 | Thyroid hormone beta agonist | 0.011 0.005 DBMET00507 | DBMET00507 | |
| 0.032 | 0.031 | 0.032 | Nicotinic acid receptor agonist | |||
| 0.022 | 0.021 | 0.022 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.041 | 0.04 | 0.059 | Carbonic anhydrase VII inhibitor | 0.059 0.02 DBMET00507 | DBMET00507 | |
| 0.007 | 0.006 | 0.007 | DNA topoisomerase III inhibitor | |||
| 0.012 | 0.012 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 DBMET00507 | DBMET00507 | |
| 0.024 | 0.024 | 0.067 | Calcium-sensing receptor agonist | 0.067 0.004 DBMET00507 | DBMET00507 | |
| 0.018 | 0.019 | 0.026 | Caspase 8 inhibitor | 0.026 0.007 DBMET00507 | DBMET00507 | |
| 0.03 | 0.031 | 0.037 | Retinoid X alpha receptor agonist | 0.037 0.022 DBMET00507 | DBMET00507 | |
| 0.017 | 0.018 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.008 DBMET00507 | DBMET00507 | |
| 0.053 | 0.056 | 0.111 | Selectin antagonist | 0.111 0.024 DBMET00507 | DBMET00507 | |
| 0.05 | 0.052 | 0.066 | Cannabinoid CB1 receptor agonist | 0.066 0.038 DBMET00507 | DBMET00507 | |
| 0.043 | 0.046 | 0.065 | Bombesin 2 receptor antagonist | 0.065 0.022 DBMET00507 | DBMET00507 | |
| 0.028 | 0.031 | 0.029 | Methionyl aminopeptidase 1 inhibitor | 0.029 0.028 DBMET00507 | DBMET00507 | |
| 0.009 | 0.013 | 0.011 | Glutamate (mGluR6) agonist | 0.011 0.01 DBMET00507 | DBMET00507 | |
| 0.178 | 0.182 | 0.283 | Hypoxia-inducible factor 1 alpha inhibitor | 0.283 0.074 DBMET00507 | DBMET00507 | |
| 0.039 | 0.044 | 0.055 | Potassium channel Kv1.3 blocker | 0.055 0.025 DBMET00507 | DBMET00507 | |
| 0.039 | 0.043 | 0.062 | Peroxisome proliferator-activated receptor alpha agonist | 0.062 0.025 DBMET00507 | DBMET00507 | |
| 0.066 | 0.071 | 0.09 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.09 0.022 DBMET00507 | DBMET00507 | |
| 0.021 | 0.027 | 0.146 | Lysine carboxypeptidase inhibitor | 0.146 0.003 DBMET00507 | DBMET00507 | |
| 0.018 | 0.024 | 0.057 | Integrin alpha4 antagonist | 0.057 0.01 DBMET00507 | DBMET00507 | |
| 0.032 | 0.04 | 0.075 | Dihydropteroate synthase inhibitor | 0.075 0.007 DBMET00507 | DBMET00507 | |
| 0.037 | 0.045 | 0.093 | Glycine transporter inhibitor | 0.093 0.013 DBMET00507 | DBMET00507 | |
| 0.025 | 0.032 | 0.033 | Lysophosphatidic acid 2 receptor antagonist | 0.033 0.018 DBMET00507 | DBMET00507 | |
| 0.048 | 0.058 | 0.076 | Glucagon-like peptide 1 agonist | 0.076 0.037 DBMET00507 | DBMET00507 | |
| 0.009 | 0.019 | 0.025 | Integrin alpha4beta1 antagonist | 0.025 0.008 DBMET00507 | DBMET00507 | |
| 0.019 | 0.029 | 0.037 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.037 0.013 DBMET00507 | DBMET00507 | |
| 0.004 | 0.015 | 0.009 | Integrin alpha5beta6 antagonist | 0.009 0.003 DBMET00507 | DBMET00507 | |
| 0.028 | 0.038 | 0.035 | Peroxisome proliferator-activated receptor delta antagonist | 0.035 0.019 DBMET00507 | DBMET00507 | |
| 0.072 | 0.083 | 0.088 | Caspase 7 inhibitor | 0.088 0.045 DBMET00507 | DBMET00507 | |
| 0.016 | 0.029 | 0.061 | Glutamate (mGluR1a) agonist | 0.061 0.004 DBMET00507 | DBMET00507 | |
| 0.016 | 0.029 | 0.021 | Lysophosphatidic acid 1 receptor antagonist | 0.021 0.015 DBMET00507 | DBMET00507 | |
| 0.02 | 0.034 | 0.039 | Glutamate (mGluR1) agonist | 0.039 0.005 DBMET00507 | DBMET00507 | |
| 0.032 | 0.047 | 0.04 | AMPA 4 receptor antagonist | 0.04 0.027 DBMET00507 | DBMET00507 | |
| 0.14 | 0.155 | 0.189 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.189 0.107 DBMET00507 | DBMET00507 | |
| 0.044 | 0.059 | 0.05 | CC chemokine 2 receptor antagonist | 0.05 0.044 DBMET00507 | DBMET00507 | |
| 0.153 | 0.168 | 0.231 | DNA damaging | 0.231 0.092 DBMET00507 | DBMET00507 | |
| 0.019 | 0.035 | 0.032 | Lysophosphatidic acid receptor 1 agonist | 0.032 0.01 DBMET00507 | DBMET00507 | |
| 0.009 | 0.025 | 0.02 | Integrin alphaVbeta6 antagonist | 0.02 0.006 DBMET00507 | DBMET00507 | |
| 0.038 | 0.055 | 0.064 | Beta 2 adrenoreceptor antagonist | 0.064 0.021 DBMET00507 | DBMET00507 | |
| 0.032 | 0.049 | 0.042 | Purinergic P2Y antagonist | 0.042 0.034 DBMET00507 | DBMET00507 | |
| 0.058 | 0.075 | 0.096 | HIV-1 integrase inhibitor | 0.096 0.027 DBMET00507 | DBMET00507 | |
| 0.05 | 0.069 | 0.058 | Prostaglandin F2 alpha antagonist | 0.058 0.051 DBMET00507 | DBMET00507 | |
| 0.034 | 0.054 | 0.097 | AICAR transformylase inhibitor | 0.097 0.005 DBMET00507 | DBMET00507 | |
| 0.01 | 0.03 | 0.019 | Carbonic anhydrase X inhibitor | 0.019 0.009 DBMET00507 | DBMET00507 | |
| 0.01 | 0.03 | 0.019 | Carbonic anhydrase VIII inhibitor | 0.019 0.009 DBMET00507 | DBMET00507 | |
| 0.028 | 0.05 | 0.039 | Oxytocin agonist | 0.039 0.033 DBMET00507 | DBMET00507 | |
| 0.033 | 0.055 | 0.09 | Stearoyl-CoA desaturase inhibitor | 0.09 0.009 DBMET00507 | DBMET00507 | |
| 0.008 | 0.03 | 0.099 | Egl nine homolog 1 inhibitor | 0.099 0.002 DBMET00507 | DBMET00507 | |
| 0.035 | 0.059 | 0.109 | Aldose reductase inhibitor | 0.109 0.016 DBMET00507 | DBMET00507 | |
| 0.029 | 0.053 | 0.092 | Membrane dipeptidase inhibitor | 0.092 0.004 DBMET00507 | DBMET00507 | |
| 0.027 | 0.052 | 0.1 | Carbonic anhydrase IV inhibitor | 0.1 0.007 DBMET00507 | DBMET00507 | |
| 0.006 | 0.031 | 0.088 | Egl nine homolog 3 inhibitor | 0.088 0.002 DBMET00507 | DBMET00507 | |
| 0.035 | 0.06 | 0.093 | Carbonic anhydrase I inhibitor | 0.093 0.02 DBMET00507 | DBMET00507 | |
| 0.046 | 0.071 | 0.082 | Neutrophil collagenase inhibitor | 0.082 0.03 DBMET00507 | DBMET00507 | |
| 0.015 | 0.041 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.021 0.014 DBMET00507 | DBMET00507 | |
| 0.032 | 0.059 | 0.081 | Ribonucleoside-diphosphate reductase inhibitor | 0.081 0.024 DBMET00507 | DBMET00507 | |
| 0.022 | 0.049 | 0.035 | 5-Alpha-reductase inhibitor | 0.035 0.028 DBMET00507 | DBMET00507 | |
| 0.023 | 0.05 | 0.051 | Complement C3a chemotactic receptor antagonist | 0.051 0.026 DBMET00507 | DBMET00507 | |
| 0.033 | 0.06 | 0.084 | Ribonucleotide reductase inhibitor | 0.084 0.025 DBMET00507 | DBMET00507 | |
| 0.02 | 0.047 | 0.033 | Retinoid X receptor agonist | 0.033 0.027 DBMET00507 | DBMET00507 | |
| 0.054 | 0.084 | 0.073 | Glutamate (mGluR7) antagonist | 0.073 0.038 DBMET00507 | DBMET00507 | |
| 0.012 | 0.043 | 0.034 | Estrogen-related receptor gamma agonist | 0.034 0.004 DBMET00507 | DBMET00507 | |
| 0.036 | 0.067 | 0.104 | Diacylglycerol O-acyltransferase inhibitor | 0.104 0.006 DBMET00507 | DBMET00507 | |
| 0.136 | 0.168 | 0.188 | Histone acetyltransferase inhibitor | 0.188 0.088 DBMET00507 | DBMET00507 | |
| 0.011 | 0.043 | 0.021 | Vitamin D receptor agonist | 0.021 0.006 DBMET00507 | DBMET00507 | |
| 0.033 | 0.065 | 0.085 | Carbonic anhydrase II inhibitor | 0.085 0.023 DBMET00507 | DBMET00507 | |
| 0.011 | 0.043 | 0.053 | AMPA 1 receptor antagonist | 0.053 0.01 DBMET00507 | DBMET00507 | |
| 0.164 | 0.197 | 0.309 | Thyroid hormone antagonist | 0.309 0.089 DBMET00507 | DBMET00507 | |
| 0.039 | 0.071 | 0.103 | Carbonic anhydrase inhibitor | 0.103 0.026 DBMET00507 | DBMET00507 | |
| 0.046 | 0.079 | 0.061 | Heat shock protein 90 beta antagonist | 0.061 0.038 DBMET00507 | DBMET00507 | |
| 0.02 | 0.053 | 0.162 | Integrin antagonist | 0.162 0.009 DBMET00507 | DBMET00507 | |
| 0.014 | 0.049 | 0.05 | AMPA 3 receptor antagonist | 0.05 0.009 DBMET00507 | DBMET00507 | |
| 0.044 | 0.08 | 0.098 | Peroxisome proliferator-activated receptor gamma agonist | 0.098 0.029 DBMET00507 | DBMET00507 | |
| 0.05 | 0.087 | 0.064 | Amidase inhibitor | 0.064 0.058 DBMET00507 | DBMET00507 | |
| 0.009 | 0.051 | 0.019 | Integrin beta6 antagonist | 0.019 0.004 DBMET00507 | DBMET00507 | |
| 0.025 | 0.066 | 0.291 | Glycine transporter 2 inhibitor | 0.291 0.004 DBMET00507 | DBMET00507 | |
| 0.028 | 0.069 | 0.057 | Leukocyte elastase inhibitor | 0.057 0.02 DBMET00507 | DBMET00507 | |
| 0.04 | 0.082 | 0.067 | Collagenase 3 inhibitor | 0.067 0.034 DBMET00507 | DBMET00507 | |
| 0.079 | 0.121 | 0.15 | Proteasome inhibitor | 0.15 0.047 DBMET00507 | DBMET00507 | |
| 0.007 | 0.049 | 0.02 | Aminopeptidase A inhibitor | 0.02 0.011 DBMET00507 | DBMET00507 | |
| 0.023 | 0.065 | 0.036 | Carboxypeptidase B inhibitor | 0.036 0.017 DBMET00507 | DBMET00507 | |
| 0.076 | 0.12 | 0.125 | DNA polymerase I inhibitor | 0.125 0.065 DBMET00507 | DBMET00507 | |
| 0.011 | 0.056 | 0.031 | Integrin alphaVbeta1 antagonist | 0.031 0.005 DBMET00507 | DBMET00507 | |
| 0.115 | 0.16 | 0.151 | MAP kinase kinase 2 inhibitor | 0.151 0.121 DBMET00507 | DBMET00507 | |
| 0.035 | 0.081 | 0.069 | Prolyl endopeptidase inhibitor | 0.069 0.016 DBMET00507 | DBMET00507 | |
| 0.022 | 0.07 | 0.042 | Factor XIIIa inhibitor | 0.042 0.021 DBMET00507 | DBMET00507 | |
| 0.153 | 0.201 | 0.29 | Thyroid hormone beta antagonist | 0.29 0.093 DBMET00507 | DBMET00507 | |
| 0.035 | 0.089 | 0.054 | Matrix metalloproteinase (membrane-type) inhibitor | 0.054 0.039 DBMET00507 | DBMET00507 | |
| 0.066 | 0.119 | 0.176 | Falcipain 3 inhibitor | 0.176 0.026 DBMET00507 | DBMET00507 | |
| 0.053 | 0.107 | 0.077 | Metalloproteinase-9 inhibitor | 0.077 0.046 DBMET00507 | DBMET00507 | |
| 0.022 | 0.078 | 0.434 | Erythropoietin receptor agonist | 0.434 0.004 DBMET00507 | DBMET00507 | |
| 0.02 | 0.078 | 0.071 | Toll-Like receptor 2 agonist | 0.071 0.018 DBMET00507 | DBMET00507 | |
| 0.022 | 0.082 | 0.031 | Melatonin receptor 1A agonist | 0.031 0.03 DBMET00507 | DBMET00507 | |
| 0.05 | 0.113 | 0.114 | Metalloproteinase-2 inhibitor | 0.114 0.032 DBMET00507 | DBMET00507 | |
| 0.036 | 0.101 | 0.072 | Matrix metalloproteinase inhibitor | 0.072 0.042 DBMET00507 | DBMET00507 | |
| 0.121 | 0.187 | 0.171 | Antiamyloidogenic | 0.171 0.122 DBMET00507 | DBMET00507 | |
| 0.005 | 0.072 | 0.021 | Ileal bile acid transport inhibitor | 0.021 0.008 DBMET00507 | DBMET00507 | |
| 0.037 | 0.104 | 0.071 | Factor III inhibitor | 0.071 0.01 DBMET00507 | DBMET00507 | |
| 0.024 | 0.093 | 0.049 | Metalloproteinase-3 inhibitor | 0.049 0.034 DBMET00507 | DBMET00507 | |
| 0.127 | 0.197 | 0.175 | Antioxidant | 0.175 0.137 DBMET00507 | DBMET00507 | |
| 0.023 | 0.093 | 0.047 | Matrix metalloproteinase 1 inhibitor | 0.047 0.041 DBMET00507 | DBMET00507 | |
| 0.028 | 0.099 | 0.051 | Integrin alpha1beta1 antagonist | 0.051 0.007 DBMET00507 | DBMET00507 | |
| 0.009 | 0.084 | 0.037 | Glycine transporter 1 inhibitor | 0.037 0.023 DBMET00507 | DBMET00507 | |
| 0.015 | 0.092 | 0.052 | Calcitonin receptor agonist | 0.052 0.016 DBMET00507 | DBMET00507 | |
| 0.169 | 0.247 | 0.209 | 15-Lipoxygenase inhibitor | 0.209 0.204 DBMET00507 | DBMET00507 | |
| 0.015 | 0.094 | 0.04 | Epoxide hydrolase 1 inhibitor | 0.04 0.011 DBMET00507 | DBMET00507 | |
| 0.046 | 0.129 | 0.074 | Histone deacetylase SIRT3 inhibitor | 0.074 0.023 DBMET00507 | DBMET00507 | |
| 0.054 | 0.137 | 0.11 | Mediator release inhibitor | 0.11 0.058 DBMET00507 | DBMET00507 | |
| 0.014 | 0.097 | 0.045 | Peptide deformylase inhibitor | 0.045 0.012 DBMET00507 | DBMET00507 | |
| 0.002 | 0.087 | 0.014 | Integrin alphaVbeta5 antagonist | 0.014 0.005 DBMET00507 | DBMET00507 | |
| 0.012 | 0.097 | 0.566 | Protocollagen prolyl hydroxylase inhibitor | 0.566 0.002 DBMET00507 | DBMET00507 | |
| 0.016 | 0.104 | 0.038 | DNA gyrase subunit B inhibitor | 0.038 0.027 DBMET00507 | DBMET00507 | |
| 0.118 | 0.208 | 0.164 | Catenin beta inhibitor | 0.164 0.076 DBMET00507 | DBMET00507 | |
| 0.084 | 0.179 | 0.281 | Angiogenesis stimulant | 0.281 0.057 DBMET00507 | DBMET00507 | |
| 0.022 | 0.119 | 0.032 | HCV polyprotein inhibitor | 0.032 0.031 DBMET00507 | DBMET00507 | |
| 0.042 | 0.14 | 0.065 | Ryanodine receptor antagonist | 0.065 0.025 DBMET00507 | DBMET00507 | |
| 0.036 | 0.134 | 0.102 | DNA helicase inhibitor | 0.102 0.005 DBMET00507 | DBMET00507 | |
| 0.091 | 0.19 | 0.197 | Insulin secretagoues | 0.197 0.038 DBMET00507 | DBMET00507 | |
| 0.157 | 0.263 | 0.219 | DNA polymerase beta inhibitor | 0.219 0.211 DBMET00507 | DBMET00507 | |
| 0.021 | 0.131 | 0.055 | Cathepsin L inhibitor | 0.055 0.044 DBMET00507 | DBMET00507 | |
| 0.016 | 0.128 | 0.073 | Integrin alpha5beta1 antagonist | 0.073 0.008 DBMET00507 | DBMET00507 | |
| 0.037 | 0.149 | 0.068 | Topoisomerase II alpha inhibitor | 0.068 0.064 DBMET00507 | DBMET00507 | |
| 0.028 | 0.151 | 0.119 | Carbonic anhydrase stimulant | 0.119 0.014 DBMET00507 | DBMET00507 | |
| 0.006 | 0.132 | 0.015 | Thyroid hormone alpha antagonist | 0.015 0.012 DBMET00507 | DBMET00507 | |
| 0.057 | 0.184 | 0.135 | Histone deacetylase class III inhibitor | 0.135 0.057 DBMET00507 | DBMET00507 | |
| 0.015 | 0.144 | 0.039 | Macrophage elastase inhibitor | 0.039 0.035 DBMET00507 | DBMET00507 | |
| 0.092 | 0.221 | 0.131 | Interleukin 6 antagonist | 0.131 0.123 DBMET00507 | DBMET00507 | |
| 0.015 | 0.145 | 0.042 | Histone deacetylase 7 inhibitor | 0.042 0.022 DBMET00507 | DBMET00507 | |
| 0.02 | 0.15 | 0.042 | Histone deacetylase 9 inhibitor | 0.042 0.023 DBMET00507 | DBMET00507 | |
| 0.098 | 0.231 | 0.158 | Free radical scavenger | 0.158 0.136 DBMET00507 | DBMET00507 | |
| 0.045 | 0.18 | 0.083 | Chymotrypsin inhibitor | 0.083 0.051 DBMET00507 | DBMET00507 | |
| 0.066 | 0.202 | 0.201 | Folate antagonist | 0.201 0.01 DBMET00507 | DBMET00507 | |
| 0.004 | 0.14 | 0.053 | Egl nine homolog 2 inhibitor | 0.053 0.004 DBMET00507 | DBMET00507 | |
| 0.032 | 0.17 | 0.062 | Sirtuin 1 inhibitor | 0.062 0.056 DBMET00507 | DBMET00507 | |
| 0.024 | 0.166 | 0.054 | HCV NS3/NS4A protease inhibitor | 0.054 0.027 DBMET00507 | DBMET00507 | |
| 0.01 | 0.151 | 0.024 | Tryptophan hydroxylase 1 inhibitor | 0.024 0.004 DBMET00507 | DBMET00507 | |
| 0.017 | 0.167 | 0.044 | Glutamate (mGluR1a) antagonist | 0.044 0.025 DBMET00507 | DBMET00507 | |
| 0.067 | 0.218 | 0.174 | Histone deacetylase SIRT1 inhibitor | 0.174 0.044 DBMET00507 | DBMET00507 | |
| 0.047 | 0.202 | 0.403 | Chelator | 0.403 0.005 DBMET00507 | DBMET00507 | |
| 0.015 | 0.171 | 0.049 | Collagenase inhibitor | 0.049 0.035 DBMET00507 | DBMET00507 | |
| 0.077 | 0.237 | 0.128 | Sphingosine 1-phosphate receptor 2 agonist | 0.128 0.044 DBMET00507 | DBMET00507 | |
| 0.015 | 0.176 | 0.05 | Glutamate (mGluR1) antagonist | 0.05 0.048 DBMET00507 | DBMET00507 | |
| 0.005 | 0.177 | 0.016 | Angiotensin-converting enzyme 2 inhibitor | 0.016 0.015 DBMET00507 | DBMET00507 | |
| 0.018 | 0.197 | 0.054 | Cyclin A1 inhibitor | 0.054 0.053 DBMET00507 | DBMET00507 | |
| 0.014 | 0.198 | 0.043 | Aminopeptidase N inhibitor | 0.043 0.038 DBMET00507 | DBMET00507 | |
| 0.007 | 0.191 | 0.038 | Integrin alphaVbeta3 antagonist | 0.038 0.005 DBMET00507 | DBMET00507 | |
| 0.035 | 0.224 | 0.083 | Protease inhibitor | 0.083 0.082 DBMET00507 | DBMET00507 | |
| 0.119 | 0.309 | 0.349 | Peptidyltransferase inhibitor | 0.349 0.012 DBMET00507 | DBMET00507 | |
| 0.02 | 0.211 | 0.06 | Aminopeptidase microsomal inhibitor | 0.06 0.039 DBMET00507 | DBMET00507 | |
| 0.003 | 0.203 | 0.02 | Neutral endopeptidase inhibitor | 0.02 0.015 DBMET00507 | DBMET00507 | |
| 0.005 | 0.231 | 0.041 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.041 0.012 DBMET00507 | DBMET00507 | |
| 0.014 | 0.242 | 0.058 | Plasminogen activator inhibitor antagonist | 0.058 0.025 DBMET00507 | DBMET00507 | |
| 0.02 | 0.251 | 0.064 | Histone deacetylase inhibitor | 0.064 0.047 DBMET00507 | DBMET00507 | |
| 0.004 | 0.239 | 0.029 | Cholecystokinin B antagonist | 0.029 0.022 DBMET00507 | DBMET00507 | |
| 0.039 | 0.283 | 0.282 | Thrombolytic | 0.282 0.027 DBMET00507 | DBMET00507 | |
| 0.013 | 0.258 | 0.062 | Plasminogen activator inhibitor | 0.062 0.038 DBMET00507 | DBMET00507 | |
| 0.005 | 0.27 | 0.055 | Cholecystokinin antagonist | 0.055 0.022 DBMET00507 | DBMET00507 | |
| 0.039 | 0.317 | 0.183 | Bone formation stimulant | 0.183 0.041 DBMET00507 | DBMET00507 | |
| 0.046 | 0.344 | 0.131 | Hematopoietic | 0.131 0.018 DBMET00507 | DBMET00507 | |
| 0.015 | 0.333 | 0.07 | Angiotensin-converting enzyme inhibitor | 0.07 0.019 DBMET00507 | DBMET00507 | |
| 0.05 | 0.372 | 0.373 | Platelet antagonist | 0.373 0.033 DBMET00507 | DBMET00507 | |
| 0.004 | 0.335 | 0.045 | Vitronectin receptor antagonist | 0.045 0.007 DBMET00507 | DBMET00507 | |
| 0.06 | 0.398 | 0.182 | Cardiotonic | 0.182 0.138 DBMET00507 | DBMET00507 | |
| 0.033 | 0.407 | 0.287 | Anticoagulant | 0.287 0.031 DBMET00507 | DBMET00507 | |
| 0.003 | 0.383 | 0.021 | Integrin beta3 antagonist | 0.021 0.012 DBMET00507 | DBMET00507 | |
| 0.051 | 0.456 | 0.099 | Factor V inhibitor | 0.099 0.07 DBMET00507 | DBMET00507 | |
| 0.009 | 0.452 | 0.049 | Elastase inhibitor | 0.049 0.044 DBMET00507 | DBMET00507 | |
| 0.012 | 0.466 | 0.039 | Neurotensin receptor antagonist | 0.039 0.038 DBMET00507 | DBMET00507 | |
| 0.012 | 0.472 | 0.059 | Nitric oxide donor | 0.059 0.051 DBMET00507 | DBMET00507 | |
| 0.012 | 0.509 | 0.077 | Thrombin inhibitor | 0.077 0.046 DBMET00507 | DBMET00507 | |
| 0.004 | 0.503 | 0.036 | Trypsin I inhibitor | 0.036 0.02 DBMET00507 | DBMET00507 | |
| 0.003 | 0.513 | 0.118 | GP IIb/IIIa receptor antagonist | 0.118 0.014 DBMET00507 | DBMET00507 | |
| 0.053 | 0.581 | 0.15 | Lipocortins synthesis antagonist | 0.15 0.105 DBMET00507 | DBMET00507 | |
| 0.016 | 0.583 | 0.093 | Multidrug resistance-associated protein 1 inhibitor | 0.093 0.092 DBMET00507 | DBMET00507 | |
| 0.023 | 0.59 | 0.101 | Electron transport complex I inhibitor | 0.101 0.08 DBMET00507 | DBMET00507 | |
| 0.014 | 0.593 | 0.067 | Trypsin inhibitor | 0.067 0.036 DBMET00507 | DBMET00507 | |
| 0.02 | 0.601 | 0.17 | Platelet aggregation inhibitor | 0.17 0.107 DBMET00507 | DBMET00507 | |
| 0.014 | 0.601 | 0.037 | Glucose-6-phosphate dehydrogenase inhibitor | 0.037 0.028 DBMET00507 | DBMET00507 | |
| 0.038 | 0.7 | 0.177 | Growth hormone agonist | 0.177 0.069 DBMET00507 | DBMET00507 | |
| 0.041 | 0.72 | 0.483 | Sodium/bile acid cotransporter inhibitor | 0.483 0.005 DBMET00507 | DBMET00507 | |
| 0.017 | 0.701 | 0.057 | Gonadotropin-releasing hormone receptor agonist | 0.057 0.046 DBMET00507 | DBMET00507 | |
| 0.004 | 0.755 | 0.028 | Trypsin II inhibitor | 0.028 0.023 DBMET00507 | DBMET00507 | |
| 0.042 | 0.845 | 0.127 | Papain-like protease (SARS coronavirus) inhibitor | 0.127 0.066 DBMET00507 | DBMET00507 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |